Drug Shortage Report for PRO-RABEPRAZOLE

Last updated on 2019-08-02 History
Report ID 84827
Drug Identification Number 02315181
Brand name PRO-RABEPRAZOLE
Common or Proper name RABEPRAZOLE
Company Name PRO DOC LIMITEE
Market Status CANCELLED POST MARKET
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 10MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-05-27
Estimated end date 2019-08-01
Actual end date 2019-08-01
Shortage status Resolved
Updated date 2019-08-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-08-02 English Compare
v9 2019-07-31 French Compare
v8 2019-07-31 English Compare
v7 2019-07-29 French Compare
v6 2019-07-29 English Compare
v5 2019-07-16 French Compare
v4 2019-07-16 English Compare
v3 2019-05-28 English Compare
v2 2019-05-27 French Compare
v1 2019-05-27 English Compare

Showing 1 to 10 of 10